edoc

Items where Author is "Martin-Liberal, Juan"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2020 | 2018 | 2015
Number of items: 3.

2020

Ladanie, Aviv and Schmitt, Andreas M. and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Herbrand, Amanda K. and Briel, Matthias and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2020) Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3 (11). e2024406.

2018

Ladanie, Aviv and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2018) The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials, 19 (1). p. 505.

2015

Diem, Stefan and Kasenda, Benjamin and Martin-Liberal, Juan and Lee, Alexander and Chauhan, Dharmisha and Gore, Martin and Larkin, James. (2015) Prognostic score for patients with advanced melanoma treated with ipilimumab. European Journal of Cancer, 51 (18). pp. 2785-2791.

This list was generated on Wed Apr 24 05:07:40 2024 CEST.